Skip to content

Cheap tests good predictors of disease progression after starting HAART

Unexpected CD4 declines seen on full dose ddI with tenofovir

Regions with fastest growing HIV epidemics have worst rates of MDR-TB says WHO

Tipranavir emergency use programme expands

Women with HIV have reduced bone density, may benefit from regular checks

Tenofovir/FTC once daily tablet ready by 2005

Less HAART use, more unsafe sex, could mean 50% leap in new HIV cases in Aussie gay men

HIV envelope may hold clues to likely treatment response

30% of mother to child HIV infections occur in the womb